Evidence map›Paper›PMID 29853804›Full record

ArticleContrast media & molecular imaging2018

Investigation of Newly Prepared Biodegradable

Guoqiang Shao, Yuebing Wang, Xianzhong Liu, Meili Zhao, Jinhua Song, Peiling Huang, Feng Wang, Zizheng Wang

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Contrast media & molecular imaging, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Guoqiang ShaoDepartment of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China.
Yuebing WangDepartment of Biochemistry, School of Medicine, Nankai University, Tianjin 300071, China.ORCID 0000-0001-6988-0788
Xianzhong LiuDepartment of Surgical Oncology, Bayi Hospital Affiliated to Nanjing University of Chinese Medicine, Nanjing 210006, China.
Meili ZhaoDepartment of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China.
Jinhua SongDepartment of Invasive Technology, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China.
Peiling HuangDepartment of Pathology, Medical College of Southeast University, Nanjing 210000, China.
Feng WangDepartment of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China.ORCID 0000-0003-1089-3095
Zizheng WangDepartment of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China.ORCID 0000-0001-5983-5326
Nanjing Medical University · CNNanjing University of Chinese Medicine · CNNankai University · CNSoutheast University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsBrachytherapyChromium CompoundsGliomaHalf-LifeHeterograftsHumansMiceMicroscopy, Electron, ScanningPhosphatesPhosphorus RadioisotopesPolylactic Acid-Polyglycolic Acid CopolymerPositron Emission Tomography Computed TomographyRadiopharmaceuticalsTissue DistributionTomography, Emission-Computed, Single-Photonchromic phosphateChromium CompoundsPhosphatesPhosphorus-32Phosphorus RadioisotopesPolylactic Acid-Polyglycolic Acid CopolymerRadiopharmaceuticals

Identifiers

PMID29853804
PMCPMC5949199
OpenAlexW2802302682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.